British consumer healthcare group Haleon on Thursday said 2025 revenue and profit growth would be weighted to the second half ...

UK's Haleon reported annual profit in line with market expectations on Thursday, as the Sensodyne toothpaste and Advil ...

Haleon posted £11.23B in FY24 revenue, with 5% organic growth. 2025 guidance expects 4-6% organic growth, with profit gains ...

Haleon plc (NYSE: HLN) Q4 2024 Earnings Call Transcript February 27, 2025 Haleon plc misses on earnings expectations.

The company, which makes Sensodyne toothpaste, ENO antacids and Centrum multivitamins, projected organic revenue would grow between 4 per cent and 6 per cent for the year, compared with a company ...

Sensodyne-maker Haleon’s annual profits rose in line with expectations last year as it got a boost in demand for its oral ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

HALEON PLC (LON:HLN) shares slid 3% in London on Thursday after the Sensodyne toothpaste maker said its revenue growth for 2025 would be weighted toward the second half of the year.

Sign up here to find us in your inbox every Wednesday, along with monthly travel and beauty guides, and the latest stories ...

Consumer healthcare giant Haleon has reported a strong financial performance for 2024, with organic revenue growth of five ...

Boss Mark Read (pictured) said that although revenues were hit by weaker client discretionary spending, growth of 2% was seen ...

Haleon declared a final dividend of 4.6 pence a share, up from 4.2 pence. For 2025, the company targets organic revenue growth in the range of 4% to 6%. It said it expects organic operating profit ...